The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Patterson Companies Inc

Nasdaq: PDCO
Last

(U.S.) $45.52

Today's change-0.46 -1.00%
Updated May 25 4:00 PM EDT. Delayed by at least 15 minutes.
 

Patterson Companies Inc

Nasdaq: PDCO
Last

(U.S.) $45.52

Today's change-0.46 -1.00%
Updated May 25 4:00 PM EDT. Delayed by at least 15 minutes.

Reversal following new 20-day high

Patterson Companies Inc closed lower Wednesday, dropping (U.S.)$0.46 or 1.00% to (U.S.)$45.52 after setting a new 20-day high. Over the last five days, shares have gained 0.75%, but are currently unchanged over the last year to date. Shares have underperformed the S&P 500 by 2.86% during the last year.

Key company metrics

  • Open(U.S.) $46.09
  • Previous close(U.S.) $45.98
  • High(U.S.) $46.36
  • Low(U.S.) $45.50
  • Bid / Ask(U.S.) $44.25 / (U.S.) $45.40
  • YTD % change+0.69%
  • Volume1,477,249
  • Average volume (10-day)1,243,650
  • Average volume (1-month)945,166
  • Average volume (3-month)931,056
  • 52-week range(U.S.) $38.51 to (U.S.) $53.07
  • Beta0.89
  • Trailing P/E24.27×
  • P/E 1 year forward18.59×
  • Forward PEG2.04×
  • Indicated annual dividend(U.S.) $0.96
  • Dividend yield2.11%
  • Trailing EPS(U.S.) $1.88
Updated May 25 4:00 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+3.63%

Based on its net profit margin of 3.63%, Patterson Companies Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.72%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJan 30, 201601/30/2016Oct 31, 201510/31/2015Aug 01, 201508/01/2015Apr 25, 201504/25/2015
Revenue1,4011,3891,1431,149
Total other revenue--------
Total revenue1,4011,3891,1431,149
Gross profit340331288334
Total cost of revenue1,0611,058855815
Total operating expense1,3051,3061,0811,042
Selling / general / administrative--------
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total244247226227
Operating income968362107
Interest income (expense), net non-operating-11-17-12-8
Gain (loss) on sale of assets--------
Other--------
Income before tax86675199
Income after tax57432065
Income tax, total29253035
Net income56353065
Total adjustments to net income--------
Net income before extra. items57432065
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items57432065
Inc. avail. to common incl. extra. items56353065
Diluted net income56353065
Dilution adjustment----00
Diluted weighted average shares9699100100
Diluted EPS excluding extraordinary itemsvalue per share0.600.430.200.65
Dividends per sharevalue per share0.220.220.220.22
Diluted normalized EPSvalue per share0.600.430.200.65